Analysts expect Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) to report $-1.24 EPS on March, 15.They anticipate $6.15 EPS change or 125.25% from last quarter’s $4.91 EPS. After having $-2.77 EPS previously, Opiant Pharmaceuticals, Inc.’s analysts see -55.23% EPS growth. The stock increased 4.10% or $0.9834 during the last trading session, reaching $24.9934. About 26,952 shares traded. Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) has 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.
Amp Capital Investors Ltd increased Axis Capital Holdings Ltd (AXS) stake by 22.67% reported in 2017Q3 SEC filing. Amp Capital Investors Ltd acquired 27,701 shares as Axis Capital Holdings Ltd (AXS)’s stock declined 7.58%. The Amp Capital Investors Ltd holds 149,888 shares with $8.59M value, up from 122,187 last quarter. Axis Capital Holdings Ltd now has $4.21 billion valuation. The stock increased 3.00% or $1.47 during the last trading session, reaching $50.67. About 371,373 shares traded. AXIS Capital Holdings Limited (NYSE:AXS) has risen 17.55% since February 14, 2017 and is uptrending. It has outperformed by 0.85% the S&P500.
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops pharmacological treatments for substance use, addictive and eating disorders. The company has market cap of $51.68 million. The firm offers NARCAN nasal spray, a treatment to reverse opioid overdoses. It has a 36.43 P/E ratio. The Company’s pipeline of product candidates includes treatments for eating disorders, including bulimia nervosa and binge eating disorders, alcohol use disorders, a long term treatment to prevent relapse for patients with opioid use disorders, cocaine use disorders, and a heroin vaccine.
Amp Capital Investors Ltd decreased Teck Resources Ltd (NYSE:TCK) stake by 97,971 shares to 538,215 valued at $11.30 million in 2017Q3. It also reduced Varian Med Sys Inc (NYSE:VAR) stake by 3,101 shares and now owns 24,713 shares. Companhia Paranaense Energ C (NYSE:ELP) was reduced too.